Skip to contentNova Tina Susan — GENOPTIX INC insider: 176 transactions · InsiderLensNova Tina Susan
- Executive Chairperson at EXAGEN INC. · on record since Jun 20, 2023
- Director at ARENA PHARMACEUTICALS INC · on record since Aug 1, 2006
- Director at CYPRESS BIOSCIENCE INC · on record since Apr 27, 2007
- Director at GENOPTIX INC · on record since Oct 29, 2007
- President and CEO at GENOPTIX INC · on record since Jan 8, 2009
- Director at CELLEGY PHARMACEUTICALS INC · on record since Feb 11, 2011
- Director at Aurinia Pharmaceuticals Inc. · on record since Jun 8, 2026
- Director at NanoString Technologies Inc · on record since May 1, 2014
- Director at VERACYTE, INC. · on record since Nov 16, 2015
- Director at HESKA CORP · on record since Jan 3, 2005
- Director at OPGEN INC · on record since Jun 12, 2017
- Director at EXAGEN INC. · on record since Sep 20, 2019
- President, CLIA U.S. at VERACYTE, INC. · on record since Jan 13, 2022
- Director at BROOKS AUTOMATION INC · on record since Feb 15, 2023
Insider trading activity of Nova Tina Susan
- Transactions on record
- 176
- since Sep 15, 2004
- Open-market buys
- 0
- Open-market sells
- 20
- $10.4M
- Companies traded
- 11
- last filing Jun 8, 2026
Figures computed from official regulatory filings — methodology.
Companies where Nova Tina Susan has traded
- Aurinia Pharmaceuticals Inc.2 tx · Jun 8, 2026
- BROOKS AUTOMATION INC4 tx · $531.6K · Feb 6, 2026
- EXAGEN INC.7 tx · Jun 12, 2025
- ARENA PHARMACEUTICALS INC46 tx · $2M · Mar 11, 2022
- VERACYTE, INC.9 tx · $297.7K · Mar 7, 2022
- OPGEN INC4 tx · Sep 3, 2019
- NanoString Technologies Inc1 tx · May 1, 2014
- CELLEGY PHARMACEUTICALS INC5 tx · Oct 17, 2013
- GENOPTIX INC91 tx · $18.8M · Mar 7, 2011
- CYPRESS BIOSCIENCE INC
Track record of Nova Tina Susan
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Nova Tina Susan
Co-insiders of Nova Tina Susan
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
5 tx · Jan 6, 2010
Versant Ventures III, LLCOPGEN INC +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 8, 2026 | AwardD | 23,931 | 0.00 USD | $0 | SEC |
| Feb 6, 2026 | Award | 5,663 | 27.85 USD | $157.7K | SEC |
| Jun 12, 2025 | AwardD | 13,500 | 0.00 USD | $0 | SEC |
| May 16, 2025 | AwardD | 63,724 | 0.00 USD | $0 | SEC |
| Feb 11, 2025 | Award | 4,040 | 52.32 USD | $211.4K | SEC |
| Jun 12, 2024 | AwardD | 13,500 | 0.00 USD | $0 | SEC |
| Feb 13, 2024 | Award | -2,465 | 65.93 USD | $162.5K | SEC |
| Jun 20, 2023 | AwardD | 13,500 | 0.00 USD | $0 | SEC |
| Feb 15, 2023 | Award | 3,604 | 0.00 USD | $0 | SEC |
| Jun 21, 2022 | AwardD | 9,000 | 0.00 USD | $0 | SEC |
| Mar 11, 2022 | Other | -17,776 | — | — | SEC |
| Mar 11, 2022 | OtherD | -5,000 | — | — | SEC |
| Mar 11, 2022 | OtherD | -5,000 | — | — | SEC |
| Mar 11, 2022 | OtherD | -15,000 | — | — | SEC |
| Mar 11, 2022 | OtherD | -4,800 | — | — | SEC |
| Mar 11, 2022 | Other | -3,067 | — | — | SEC |
| Mar 11, 2022 | OtherD | -7,202 | — | — | SEC |
| Mar 11, 2022 | OtherD | -5,000 | — | — | SEC |
| Mar 7, 2022 | AwardD | 103,043 | 0.00 USD | $0 | SEC |
| Mar 7, 2022 | Award | 56,546 | 0.00 USD | $0 | SEC |
| Mar 4, 2022 | Other | -10,695 | 27.84 USD | $297.7K | SEC |
| Jun 21, 2021 | AwardD | 9,000 | 0.00 USD | $0 | SEC |
| Jun 15, 2021 | AwardD | 7,202 | 0.00 USD | $0 | SEC |
| Jun 15, 2021 | Award | 3,067 | 0.00 USD | $0 | SEC |
| Aug 28, 2020 | Exercise | 12,500 | 20.00 USD | $250K | SEC |